Alteration of Cellular Reduction Potential Will Change (64)Cu-ATSM Signal With or Without Hypoxia

Therapies targeting reductive/oxidative (redox) metabolism hold potential in cancers resistant to chemotherapy and radiation. A redox imaging marker would help identify cancers susceptible to redox-directed therapies. Copper(II)-diacetyl-bis(4-methylthiosemicarbazonato) (Cu-ATSM) is a PET tracer dev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Nucl Med
Autori principali: Floberg, John M., Wang, Lingjue, Bandara, Nilantha, Rashmi, Ramachandran, Mpoy, Cedric, Garbow, Joel R., Rogers, Buck E., Patti, Gary J., Schwarz, Julie K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Society of Nuclear Medicine 2020
Soggetti:
Molecular Imaging
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067520/
https://ncbi.nlm.nih.gov/pubmed/31586008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.230805
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi